Roche Holding AG logo

Roche Holding AG (ROG)

Market Open
31 Mar, 15:20
SIX SIX
290. 50
CHF
-6.2
-2.09%
CHF
- Market Cap
17.54 P/E Ratio
10.86% Div Yield
1,408,463 Volume
0 Eps
296.7 CHF
Previous Close
Day Range
289.7 295.1
Year Range
212.9 313.8

Summary

ROG trading today lower at 290.5 CHF, a decrease of 2.09% from yesterday's close, completing a monthly increase of 2.22% or 6.3 CHF. Over the past 12 months, ROG stock gained 12.47%.
ROG pays dividends to its shareholders, with the most recent payment made on Yesterday at 12:00 AM. The next estimated payment will be in 1 day ago on Yesterday at 12:00 AM for a total of 9.7 CHF.
The last earnings report, released on Jan 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on SIX (CHF).
Want to track ROG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

ROG Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Roche Holding AG (ROG) FAQ

What is the stock price today?

The current price is 290.50 CHF.

On which exchange is it traded?

Roche Holding AG is listed on SIX.

What is its stock symbol?

The ticker symbol is ROG.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Roche Holding AG ever had a stock split?

No, there has never been a stock split.

Roche Holding AG Profile

Drug Manufacturers - General Industry
Healthcare Sector
Dr. Severin Schwan Ph.D. CEO
SIX Exchange
CH0012032048 ISIN
US Country
103,605 Employees
27 Mar 2025 Last Dividend
4 May 2001 Last Split
- IPO Date
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Contact Information

Address: Grenzacherstrasse 124, Basel, Switzerland, 4058
Phone: 41 61 688 11 11